← Scroll for more →
Financial Statements — CRNT
Balance Sheet
(in millions USD)| Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 38.37 | 29.22 | 35.31 | 26.30 | 28.24 | 24.53 | 22.95 | 23.59 | 17.08 | 28.67 |
| Accounts Receivable | 99.67 | 124.05 | 149.62 | 112.90 | 104.32 | 107.59 | 100.03 | 115.74 | 107.83 | 107.40 |
| Inventory | 61.59 | 59.94 | 59.69 | 59.49 | 68.81 | 67.84 | 72.01 | 60.71 | 61.40 | 52.32 |
| Total Current Assets | 225.20 | 234.21 | 261.04 | 216.29 | 217.94 | 215.77 | 210.75 | 217.80 | 203.48 | 206.52 |
| Property, Plant & Equipment | 39.95 | 38.01 | 36.76 | 33.85 | 30.66 | 30.49 | 29.46 | 30.89 | 29.38 | 30.04 |
| Goodwill | 11.01 | 11.05 | 7.75 | 7.75 | 7.75 | -- | -- | -- | -- | -- |
| Intangible Assets | 23.18 | -- | 16.79 | -- | 16.40 | -- | 8.21 | -- | 6.27 | -- |
| Total Non-current Assets | 91.84 | 94.18 | 83.96 | 82.75 | 80.58 | 78.69 | 78.57 | 87.18 | 89.08 | 87.90 |
| Total Assets | 317.04 | 328.39 | 345.00 | 299.04 | 298.52 | 294.46 | 289.32 | 304.98 | 292.56 | 294.42 |
| Accounts Payable | 70.78 | 73.76 | 91.16 | 67.41 | 67.03 | 62.77 | 67.38 | 72.03 | 69.44 | 65.99 |
| Short-term Debt | 19.00 | 20.50 | 25.20 | 28.45 | 32.60 | 39.55 | 37.50 | 31.90 | 14.80 | 11.00 |
| Total Current Liabilities | 120.23 | 125.87 | 151.45 | 127.32 | 132.95 | 132.23 | 132.84 | 135.69 | 115.68 | 106.65 |
| Total Non-current Liabilities | 24.06 | 30.74 | 27.22 | 28.21 | 31.55 | 35.85 | 36.70 | 37.31 | 39.73 | 41.46 |
| Total Liabilities* | 144.29 | 156.61 | 178.67 | 155.53 | 164.51 | 168.08 | 169.54 | 173.01 | 155.41 | 148.11 |
| Retained Earnings | (253.21) | (253.37) | (251.12) | (266.95) | (275.19) | (277.35) | (281.41) | (265.53) | (261.72) | (249.77) |
| Total Stockholder Equity | 172.75 | 171.78 | 166.33 | 143.50 | 134.02 | 126.38 | 119.78 | 131.97 | 137.15 | 146.31 |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Total Revenue | 170.91 | 184.59 | 169.56 | 140.99 | 136.89 |
| Cost of Revenue | 113.38 | 119.06 | 111.03 | 100.25 | 94.86 |
| Gross Profit | 57.54 | 65.53 | 58.53 | 40.74 | 42.03 |
| Research & Development | 15.58 | 17.23 | 15.75 | 14.29 | 14.97 |
| Selling, General & Admin | 12.38 | 8.16 | 11.54 | 9.90 | 10.29 |
| Total Operating Expenses | 56.41 | 50.95 | 48.16 | 42.32 | 41.19 |
| Operating Income | 1.13 | 14.58 | 10.37 | (1.58) | 0.84 |
| Pretax Income | (0.78) | 9.80 | 7.03 | (3.10) | (2.01) |
| Tax Provision | 1.47 | 1.56 | 2.97 | 0.71 | 0.87 |
| Net Income | (2.25) | 8.24 | 4.06 | (3.81) | (2.88) |
| Basic EPS | (0.03) | 0.10 | 0.05 | (0.05) | -- |
| Diluted EPS | (0.03) | 0.09 | 0.05 | (0.05) | -- |
← Scroll for more columns →
Cash Flow Statement
(in millions USD)| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 | Q2 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | 13.37 | 11.35 | 6.69 | (4.99) | (4.61) |
| Capital Expenditures | 7.43 | 7.96 | 5.47 | 5.37 | 3.93 |
| Free Cash Flow* | 5.95 | 3.39 | 1.22 | (10.36) | (8.54) |
| Investing Cash Flow | (15.71) | (8.94) | (7.31) | (5.80) | (3.73) |
| Financing Cash Flow | (4.05) | (3.61) | 2.08 | 17.21 | 9.96 |
← Scroll for more columns →
* Derived from reported values